Hospitals News

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2026 financial results and guidance will be released on Tuesday, August 4, 2026 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s second quarter 2026 financial results and provide a business update.A live webcast will be available in the Investors section of www.gilead.com and will be archived there for one...

MUNICH--(BUSINESS WIRE)--LRE Medical will showcase a connected IVD instrument demonstration at ADLM 2026, illustrating how secure connectivity can be engineered into custom diagnostic systems from the earliest stages of development. Visitors will see how embedded software, cloud connectivity and cybersecurity work together within the instrument architecture to enable remote services, lifecycle management and future AI-enabled applications. As diagnostic instruments become increasingly software-...

OTTAWA--(BUSINESS WIRE)--The union representing nearly 1,000 workers at Queensway Carleton is slamming the provincial government for the elimination of 101 jobs at the hospital. The hospital has notified CUPE 2875 about the layoffs, citing insufficient funding amidst rising costs of operations including drugs, salaries, and supplies. The impacted jobs include 87 nurses, seven housekeepers, and four emergency department personal care aides. “While the Premier is focused on private jets and takin...

FOSTER CITY, Calif. & RAHWAY, N.J.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the detailed outcomes from the Phase 3 ISLEND-1 and ISLEND-2 trials will be presented for the first time at the 26th International AIDS Conference (AIDS 2026). The primary endpoint results at Week 48 showed that the investigational once-weekly oral single-tablet HIV treatment regimen of islatravir 2 mg/lenacap...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 26th International AIDS Conference (AIDS 2026) taking place in Rio de Janeiro, Brazil, from July 26-31. As a leader in HIV innovation, Gilead will share new scientific data from its HIV research and development programs and provide updates on its strategic initiatives and key collaborations. The data to be presented, together with Gilead-led symposia and community forums,...

BOTHELL, Wash.--(BUSINESS WIRE)--FUJIFILM Sonosite, Inc., a global leader in point-of-care ultrasound (POCUS) solutions, today announced the launch of Sonosite iLOOK, a compact ultrasound solution designed specifically for vascular access. Sonosite iLOOK combines a purpose-built user interface, wireless transducer technology, and flexible mounting options in a streamlined solution intended to support vascular access procedures at the bedside Developed specifically for vascular access workflows,...

CHICAGO--(BUSINESS WIRE)--Chamberlain University, America’s largest school of nursing and a Covista institution, today announced it will open a new campus in Salt Lake City, Utah. The campus continues Chamberlain's national expansion strategy to address the U.S. healthcare workforce shortage. The university will begin accepting applications on July 21, 2026, with pre-licensure Bachelor of Science in Nursing (BSN) classes beginning October 26, 2026. The announcement comes as the region grapples...

SAN ANTONIO--(BUSINESS WIRE)--Together, these leaders solidify Carenet’s client-centric operating model from strategy through execution....

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Pacific Clinics selects Netsmart to advance integrated behavioral healthcare across California through care coordination, AI & automation technology....

DURHAM, N.C.--(BUSINESS WIRE)--The Emily Program, a national leader in eating disorder specialty care and behavioral health services, today announced it is offering on-site Spravato® (esketamine) nasal spray treatment at its adult inpatient and residential treatment center in Durham, North Carolina. The program is among a limited number of eating disorder treatment programs nationwide to administer the therapy on-site for eligible adults with co-occurring treatment-resistant depression (TRD) or...